Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.716467
Abstract: Introduction Melphalan, as a bifunctional alkylating agent has been shown to be selectively efficient in BRCA-deficient case reports of epithelial ovarian cancer (EOC). The clinical benefit of melphalan on unselected platinum-resistant EOC population and stratified… read more here.
Keywords: melphalan promising; platinum; months range; treatment ... See more keywords